Recombinant adenovirus: A gene transfer vector for study and treatment of CNS diseases

Experimental Neurology

Volumn 144, Issue 1, 1997, Pages 125-130

  Davidson, Beverly L ^a   Bohn, Martha C ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GENE TRANSFER; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; STROKE;

EID: 0031105816     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.6398     Document Type: Article

References (66)

1. 1. Akli, S., C. Caillaud, E. Vigne, L. D. Stratford-Perricaudet, M. Perricaudet, and M. R. Peschankski. 1993. Transfer of a foreign gene into the brain using adenovirus vectors. Nat. Genet. 3: 224-228.
2. 2. Armentano, D., C. C. Sookdeo, K. M. Hehir, R. J. Gregory, J. A. St. George, G. A. Prince, S. C. Wadsworth, and A. E. Smith. 1995. Characterization of an adenovirus gene transfer vector containing an E4 deletion. Hum. Gene Ther. 6: 1343-1353.
3. 3. Bajocchi, G., S. H. Feldman, R. G. Crystal, and A. Mastrangeli. 1993. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nat. Genet. 3: 229-234.
4. 4. Bencsics, C., S. R. Wachtel, S. Milatien, K. Hatakeyama, J. B. Becker, and U. J. Kang. 1996. Double transduction with GTP cyclohydrolase I and tyrosine hydroxylase is necessary for spontaneous synthesis of L-dopa by primary fibroblast. J. Neurosci. 16: 4449-4456.
5. 5. Bennett, J., T. Tanabe, D. Sun, Y. Zeng, H. Kjeldbye, P. Gouras, and A. M. Maguire. 1996. Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy. Nat. Med. 2: 649-654.
6. 6. Bennett, J., J. Wilson, D. Sun, B. Forbes, and A. Maguire. 1994. Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest. Ophthalmol. Visual Sci. 35: 2535-2542.
7. 7. Betz, A. L., G. W. Goldstein, and R. Katzman. 1989. Blood-brain-cerebrospinal fluid barriers. Pages 591-606 in G. J. Siegel, B. Agranoff, R. W. Albers, and P. Molinoff, Eds., Basic Neurochemistry. Raven Press, New York.
8. 8. Betz, A. L., G. Y. Yang, and B. L. Davidson. 1995. Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J. Cereb. Blood Flow Metab. 15: 547-551.
9. 9. Birkenmeier, E. H., J. E. Barker, C. A. Vogler, J. W. Kyle, W. S. Sly, B. Gwynn, B. Levy, and C. Pegors. 1991. Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. Blood 78: 3081-3092.
10. 10. Byrnes, A. P., J. E. Rusby, M. J. A. Wood, and H. M. Charlton. 1995. Adenovirus gene transfer causes inflammation in the brain. Neuroscience 66: 1015-1024.
11. 11. Castel-Barthe, M. N., F. Jazat-Poindessous, P. Barneoud, E. Vigne, F. Revah, J. Mallet, and Y. Lamour. 1996. Direct intracerebral nerve growth factor gene transfer using a recombinant adenovirus: Effect on basal forebrain cholinergic neurons during aging. Neurobiol. Dis. 3: 76-86.
12. 12. Chen, S. H., H. D. Shine, J. C. Goodman, R. G. Grossman, and S. L. Woo. 1994. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA 91: 3054-3057.
13. 13. Chen, S. H., H. D. Shine, J. C. Goodman, R. G. Grossman, and S. L. Woo. 1994. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA 91: 3054-3057.
14. 14. Choi-Lundberg, D. L., Q. Lin, Y-N. Chang, C. M. Hay, H. Mohajeri, B. L. Davidson, and M. C. Bohn. 1996. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Submitted for publication.
15. 15. Davidson, B. L., E. D. Allen, K. F. Kozarsky, J. M. Wilson, and B. J. Roessler. 1993. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat. Genet. 3: 219-223.
16. 16. Davidson, B. L., S. E. Doran, D. S. Shewach, J. M. Latta, J. W. Hartman, and B. J. Roessler. 1994. Expression of Escherichia coli beta-galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral-mediated gene transfer. Exp. Neurol. 125: 258-267.
17. 17. Doran, S. E., X. D. Ren, A. L. Betz, M. A. Pagel, E. A. Neuwelt, B. J. Roessler, and B. L. Davidson. 1995. Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption. Neurosurgery 36: 965-970.
18. 18. Draghia, R., C. Caillaud, R. Manicom, A. Pavirani, A. Kahn, and L. Poenaru. 1995. Gene delivery into the central nervous system by nasal instillation in rats. Gene Ther. 2: 418-423.
19. 19. During, M. J. 1995. HSV vectors in the mammalian brain: Molecular analysis of neuronal physiology, generation of genetic models, and gene therapy of neurological disorders. Pages 89-107 in M. G. Kaplitt and A. D. Loewy, Eds., Viral Vectors: Gene Therapy and Neuroscience Applications. Academic Press, San Diego.
20. 20. During, M. J., J. R. Naegele, K. L. O'Malley, and A. I. Geller. 1994. Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266: 1399-1403.
21. 21. Eck, S. L., J. B. Alavi, A. Alavi, A. Davis, D. Hackney, K. Judy, J. Mollman, P. C. Phillips, E. B. Wheeldon, and J. M. Wilson. 1996. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: A phase I trial. Hum. Gene Ther. 7: 1465-1482.
22. 22. Fang, B., H. Wang, G. Gordon, D. A. Bellinger, M. S. Read, K. M. Brinkhous, S. L. Woo, and R. C. Eisensmith. 1996. Lack of persistence of E1 recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs. Gene Ther. 3: 217-222.
23. 23. Fisher, K. J., H. Choi, J. Burda, C. Shu-Jen, and J. M. Wilson. 1996. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217: 11-22.
24. 24. Frim, D. M., T. A. Uhler, W. R. Galpern, M. F. Beal, X. O. Breakefield, and O. Isacson. 1994. Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proc. Natl. Acad. Sci. USA 91: 5104-5108.
25. 25. Ghadge, G. D., R. P. Roos, U. J. Kang, R. Wollmann, P. S. Fishman, A. M. Kalynych, E. Barr, and J. M. Leiden. 1995. CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses. Gene Ther. 2: 132-137.
26. 26. Gorziglia, M. I., M. J. Kadan, S. Yei, J. Lim, G. M. Lee, R. Luthra, and B. C. Trapnell. 1996. Elimination of both E1 and E2a from adenovirus vectors further improves prospects for in vivo human gene therapy. J. Virol. 70: 4173-4178.
27. 27. Hagan, P., J. D. Barks, M. Yabut, B. L. Davidson, B. Roessler, and F. S. Silverstein. 1996. Adenovirus-mediated over-expression of interleukin-1 receptor antagonist reduces susceptibility to excitotoxic brain injury in perinatal rats. Neurosci. 75(4): 1033-1045.
28. 28. Hehir, K. M., D. Armentano, L. M. Cardoza, T. L. Choquette, P. B. Berthelette, G. A. White, L. A. Couture, M. B. Everton, J. Keegan, J. M. Martin, D. A. Pratt, M. P. Smith, A. E. Smith, and S. C. Wadsworth. 1997. Molecular characterization of replication competent variants of adenovirus vectors and genome modifications to prevent their occurence. J. Virol., in press.
29. 29. Ikari, H., L. Zhang, J. M. Chernak, A. Mastrangeli, S. Kato, H. Kuo, R. G. Crystal, D. K. Ingram, and G. S. Roth. 1995. Adenovirus-mediated gene transfer of dopamine D2 receptor cDNA into rat striatum. Brain Res. Mol. Brain Res. 34: 315-320.
30. 30. Jinnah, H. A., T. Page, and T. Friedmann. 1993. Brain purines in a genetic mouse model of Lesch-Nyhan disease. J. Neurochem. 60: 2036-2045.
31. 31. Kaplitt, M. G., P. Leone, R. J. Samulski, X. Xiao, D. W. Pfaff, K. L. O'Malley, and M. J. During. 1994. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8: 148-154.
32. 32. Kochanek, S., P. R. Clemens, K. Mitani, H. H. Chen, S. Chan, and C. T. Caskey. 1996. A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and B-galactosidase. Proc. Natl. Acad. Sci. USA 93: 5731-5736.
33. 33. Lawrence, M. S., D. Y. Ho, G. H. Sun, G. K. Steinberg, and R. M. Sapolsky. 1996. Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J. Neurosci. 16: 486-496.
34. 34. Lawrence, M. S., G. H. Sun, D. M. Kunis, T. C. Saydam, R. Dash, D. Y. Ho, R. M. Sapolsky, and G. K. Steinberg. 1996. Overexpression of the glucose transporter gene with a herpes simplex viral vector protects striatal neurons against stroke. J. Cereb. Blood Flow Metab. 16: 181-185.
35. 35. Le Gal La Salle, G., J. J. Robert, S. Berrard, V. Ridoux, L. D. Stratford-Perricaudet, M. Perricaudet, and J. Mallet. 1993. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259: 988-990.
36. 36. Lefebvre, P. P., T. R. Van de Water, T. Weber, B. Register, and G. Monnen. 1991. Growth factor interactions in cultures of dissociated adult acoustic ganglia: Neuronotrophic effects. Brain Res. 567: 306-312.
37. 37. Li, T., M. Adamian, D. J. Roof, E. L. Berson, T. P. Dryja, B. J. Roessler, and B. L. Davidson. 1994. In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector. Invest. Ophthalmol. Visual Sci. 35: 2543-2549.
38. 38. Li, T., and B. L. Davidson. 1995. Phenotype correction in retinal pigment epithelium in murine mucopolysaccharidosis VII by adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 92: 7700-7704.
39. 39. Linnik, M. D., P. Zahos, M. D. Geschwind, and H. J. Federoff. 1995. Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke 26: 1670-1674.
40. 40. Martinou, J-C., M. Dubois-Douphin, J. K. Staple, I. Rodriguez, H. Frankowsky, M. Missotten, P. Albertini, D. Talabot, S. Catsicas, C. Pietra, and J. Huarte. 1994. Overexpression of Bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13: 1017-1030.
41. 41. McCoy, R. D., B. L. Davidson, B. J. Roessler, G. B. Huffnagle, S. L. Janich, T. J. Laing, and R. H. Simon. 1995. Pulmonary inflammation induced by incomplete or inactivated particles. Hum. Gene Ther. 6: 1553-1560.
42. 42. McCoy, R. D., B. L. Davidson, B. J. Roessler, G. B. Huffnagle, and R. H. Simon. 1995. Expression of human interleukin-1 receptor antagonist in mouse lungs using a recombinant adeno-virus: Effects on vector-induced inflammation. Gene Ther. 2: 437-442.
43. 43. Milligan, C. E., D. Prevette, H. Yaginuma, S. Homma, C. Cardwell, L. C. Fritz, K. J. Tomaselli, R. W. Oppenheim, and L. M. Schwartz. 1995. Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro. Neuron 15: 385-393.
44. 44. Muldoon, L. L., G. Nilaver, R. A. Kroll, M. A. Pagel, X. O. Breakefield, E. A. Chiocca, B. L. Davidson, R. Weissleder, and E. A. Neuwelt. 1995. Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus and iron oxide particles to normal rat brain. Am. J. Pathol. 147(6): 1840-1851.
45. 45. Nilaver, G., L. L. Muldoon, R. A. Kroll, M. A. Pagel, X. O. Breakefield, B. L. Davidson, and E. A. Neuwelt. 1995. Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption. Proc. Natl. Acad. Sci. USA 92: 9829-9833.
46. 46. Ooboshi, H., Y. Chu, C. D. Rios, F. M. Faraci, B. L. Davidson, and D. D. Heistad. 1996. Altered vascular function following adeno-virus-mediated overexpression of endothelial nitric oxide synthase. Unpublished.
47. 47. Ooboshi, H., M. J. Welsh, C. D. Rios, B. L. Davidson, and D. D. Heistad. 1995. Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue. Circ. Res. 77: 7-13.
48. 48. Pechan, P. A., T. Yoshida, N. Panahian, M. A. Moskowitz, and X. O. Breakefield. 1995. Genetically modified fibroblasts producing NGF protect hippocampal neurons after ischemia in the rat. NeuroReport 6: 669-672.
49. 49. Perez-Cruet, M. J., T. W. Trask, S. H. Chen, J. C. Goodman, S. L. Woo, R. G. Grossman, and H. D. Shine. 1994. Adenovirus-mediated gene therapy of experimental gliomas. J. Neurosci. Res. 39: 506-511.
50. 50. Plumb, T. J., A. Bosch, B. J. Roessler, D. S. Shewach, and B. L. Davidson. 1996. Hypoxanthine-guanine phosphoribosyltransferase (HPRT) expression in the CNS of HPRT deficient mice following adenoviral mediated gene transfer. Neurosci. Lett. 214: 159-162.
51. 51. Relton, J. K., and N. J. Rothwell. 1992. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 29: 243-246.
52. 52. Ross, B. D., B. Kim, and B. L. Davidson. 1995. Assessment of ganciclovir toxicity to experimental intracranial gliomas following recombinant adenoviral-mediated transfer of the herpes simplex virus thymidine kinase gene by magnetic resonance imaging and proton magnetic resonance spectroscopy. Clin. Cancer Res. 1: 651-657.
53. 53. Sabate, O., P. Horellou, E. Vigne, P. Colin, M. Perricaudet, M. H. Buc-Caron, and J. Mallet. 1995. Transplantation to the rat brain of human neural progenitors that were genetically modified using adenoviruses. Nat. Genet. 9: 256-260.
54. 54. Sands, M. S., J. E. Barker, C. Vogler, B. Levy, B. Gwynn, N. Galvin, W. S. Sly and E. Birkenmeier. 1993. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. Lab. Invest. 68: 676-686.
55. 55. Shewach, D. S., L. K. Zerbe, T. L. Hughes, B. J. Roessler, X. O. Breakefield, and B. L. Davidson. 1994. Enhanced cytotoxicity of antiviral drugs mediated by adenovirus directed transfer of the herpes simplex virus thymidine kinase gene in rat glioma cells. Cancer Gene Ther. 1: 107-112.
56. 56. Walkley, S. U., M. A. Thrall, K. Dobrenis, M. Huang, P. A. March, D. A. Siegel, and S. Wurzelmann. 1994. Bone marrow transplantation corrects the enzyme defect in neurons of the central nervous system in lysosomal storage disease. Proc. Natl. Acad. Sci. USA 91: 2970-2974.
57. 57. Willis, K. N., D. C. Maneval, P. Menzel, M. P. Harris, S. Sutjipto, M-T. Vaillancourt, W-H. Huang, D. Johnson, S. C. Anderson, S. F. Wen, R. Bookstein, H. M. Shepard, and R. J. Gregory. 1994. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. Hum. Gene Ther. 5: 1079-1088.
58. 58. Wolfe, J. H., M. S. Sands, J. E. Barker, B. Gwynn, L. B. Rowe, C. A. Vogler, and E. H. Birkenmeier. 1992. Reversal of pathology in murine mucopolysacchardiosis type VII by somatic cell gene transfer. Nature 360: 749-753.
59. 59. Wu, C. L., and D. W. Melton. 1993. Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyltransferase-deficient mice. Nat. Genet. 3: 235-240.
60. 60. Yang, Y., K. Greenough, and J. M. Wilson. 1996. Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver. Gene Ther. 3: 412-420.
61. 61. Yang, Y., F. A. Nunes, K. Berencsi, E. Gonczol, J. F. Engelhardt, and J. M. Wilson. 1994. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat. Genet. 7: 362-369.
62. 62. Yang, Y., Q. Su, I. S. Grewal, R. Schilz, R. A. Flavell, and J. M. Wilson. 1996. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues. J. Virol. 70(9): 6370-6377.
63. 63. Yang, Y., G. Trinchieri, and J. M. Wilson. 1995. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat. Med. 1: 890-893.
64. 64. Yang, Y., and J. M. Wilson. 1995. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J. Immunol. 155: 2564-2570.
65. 65. Yatziv, S., L. Weiss, S. Morecki, Z. Fuks, and S. Slavin. 1982. Long-term enzyme replacement therapy in beta-glucuronidase-deficient mice by allogeneic bone marrow transplantation. J. Lab. Clin. Med. 99: 792-797.
66. 66. Yoshimoto, Y., Q. Lin, T. Collier, D. Frim, X. O. Breakefield, and M. C. Bohn. 1995. Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease. Brain Res. 691: 25-36.